Seller record · transcendcompany.com

Transcend

Recorded September 2026 · Standard v1.1

Fails 4 of 8 criteria. S3, pharmacy identification: Nine pages were read, covering the terms, questions, about, contact and treatment surfaces, and a site-wide notice states that the seller provides no pharmacy services and names no facility. 3 more criteria also fail; see the table below.

Telehealth service. Passes 2 of 8 criteria. 2 not verified, counting neither way. Recorded against Standard v1.1.

A physician-led hormone and longevity service offering prescription peptide programs beside its own supplements. It describes itself as a management platform that provides no medical or pharmacy services and employs no healthcare providers.

Operating entity The footer, the about page, the contact page and the refund policy were all read, and none of the four prints a legal entity name.

Dispositions

Code	Criterion	Disposition	Where it was read
S1	Prescriber requirement	PASS	transcendcompany.com
S2	Prescription gating	NOT VERIFIED	transcendcompany.com/pages/schedule-a-consultation
S3	Pharmacy identification	FAIL	transcendcompany.com/pages/faq
S4	Compounding disclosure	NOT VERIFIED	transcendcompany.com/pages/treatment-options
S5	Analytical documentation	FAIL	transcendcompany.com/pages/faq
S6	Business address	FAIL	transcendcompany.com/pages/contact
S7	Price disclosure	FAIL	transcendcompany.com/pages/tesamorelin
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

What was read, where, and on what date, for each disposition in the table above.

S1PASSThe homepage states that medical services are provided by licensed clinicians and that treatment decisions follow a clinical evaluation, and it names no individual prescriber.Source: transcendcompany.com.

S2NOT VERIFIEDThe order path for a prescription peptide did not resolve, because the page the site offers for scheduling a consultation carries no intake form and no further step. The check is open.Source: transcendcompany.com/pages/schedule-a-consultation.

S3FAILNine pages were read, covering the terms, questions, about, contact and treatment surfaces, and a site-wide notice states that the seller provides no pharmacy services and names no facility.Source: transcendcompany.com/pages/faq.

S4NOT VERIFIEDA statement of whether the prescription peptides sold are compounded did not resolve, because the words compounded and compounding appear on none of the nine pages read. The check is open.Source: transcendcompany.com/pages/treatment-options.

S5FAILNine pages were searched for thirteen certificate and testing terms, and none returns a certificate, a lot number or a purity figure.Source: transcendcompany.com/pages/faq.

S6FAILNine pages were read, covering footer, about, contact, refund and treatment surfaces, and the contact page offers a form and an email address in place of any street address.Source: transcendcompany.com/pages/contact.

S7FAILNo price appears for any prescription peptide program on the nine pages read, and each program page offers a consultation instead of a figure.Source: transcendcompany.com/pages/tesamorelin.

S8PASSNo letter names the storefront in the FDA index, and no action has halted the business; control letter found in the same run.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: prescription tesamorelin programs, semaglutide GLP-1 programs, hormone therapy, supplements.

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.